YOLFTbeta
Immunovia publ AB

Immunovia publ AB

IMMNOV · ST · Healthcare / Diagnostics & Research

0.0313SEK-0.00 (-2.80%)

Price History

Full chart

Market Stats

Previous Close0.0322
Open0.0328
Day Range0.0302 – 0.033
52-Week Range0.072 – 0.375
Volume7.06M
Market Cap51.12M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.16
Dividend Yield0.00%
Beta2.64
50-Day Avg0.1514
200-Day Avg0.1843

About

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Jeff Borcherding
  • Employees18
  • HeadquartersMedicon Village, Lund, Sweden, 223 63, Sweden
  • Websitehttps://www.immunovia.com

Leadership

  • Mr. Jeff BorcherdingGlobal Chief Executive Officer & President · b. 1973
  • Ms. Sarah DeDiemarVP of Sales & Marketing

Financials

Income Statement

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue208.81K1.18M359.17K205.19K177.28K148.96K332.60K356.00K362.00K844.00K1.15M1.57M931.00K685.00K
Growth (%)-+464.45%-69.53%-42.87%-13.60%-15.97%+123.27%+7.04%+1.69%+133.15%+35.66%+37.55%-40.89%-26.42%
Cost of Revenue190.70K1.70M7.28M-16.79M-24.29M-24.04M-25.05M-26.72M-40.02M-14.97M4.21M6.68M107.89M80.19M
Gross Profit18.11K-525.76K-6.92M17.00M24.47M24.19M25.38M27.07M40.38M15.81M-3.07M-5.11M931.00K-79.50M
Gross Margin8.68%-44.61%-1928.05%8283.16%13802.69%16238.78%7632.32%7604.49%11155.25%1873.58%-267.77%-324.25%100.00%-11606.42%
Operating Expense288.92K1.09M2.03M24.42M39.45M69.71M113.09M141.42M175.06M182.55M188.08M291.35M110.34M0
Operating Income-270.80K-1.61M-8.96M-7.42M-14.98M-45.52M-87.71M-114.35M-134.68M-166.74M-191.15M-296.46M-109.41M-79.50M
Operating Margin-129.69%-136.91%-2494.54%-3618.12%-8448.60%-30557.77%-26371.06%-32120.79%-37203.87%-19756.04%-16694.32%-18822.86%-11751.99%-11606.42%
EBITDA-1.89K-1.10M-8.60M-7.10M-14.20M-43.97M-83.75M-104.75M-134.85M-135.47M-141.58M-166.56M-61.27M-77.18M
EBITDA Margin-0.90%-93.07%-2394.39%-3457.91%-8009.33%-29516.52%-25181.98%-29424.72%-37251.93%-16051.07%-12364.98%-10575.17%-6580.56%-11267.01%
Net Income-258.90K-1.60M-8.86M-7.38M-14.72M-45.23M-86.54M-114.52M-147.45M-157.40M-145.03M-309.44M-76.54M-145.91M
Net Income Margin-123.99%-135.45%-2466.58%-3598.41%-8304.88%-30364.72%-26019.22%-32168.82%-40732.32%-18649.05%-12666.72%-19646.92%-8221.37%-21301.46%
R&D---16.79M24.29K24.04M26.05M34.20M48.10M43.00M47.90M34.42M28.45M-
R&D as % of Total Revenue---8183.03%13.70%16138.91%7831.75%9606.74%13287.29%5094.79%4183.58%2185.14%3055.85%-
Interest Expense-3.11K4868221.15K10.17K6971.32M1.42M1.43M1.60M1.17M1.86M66.07M
Interest Expense % of Total Revenue-0.26%0.14%0.40%0.65%6.83%0.21%370.22%391.71%169.67%139.74%74.03%199.79%9645.26%

Balance Sheet

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.00M7.47M38.87M91.51M283.41M250.77M477.38M419.37M661.18M493.81M300.59M98.68M33.04M88.21M
Total Liabilities1.67M2.53M3.13M7.71M6.78M13.97M15.43M61.76M61.77M59.91M56.79M31.69M21.39M23.48M
Total Equity1.33M4.94M35.74M83.80M276.63M236.80M461.95M357.61M599.40M433.90M243.80M66.99M11.65M64.73M
Cash692.89K3.61M31.80M75.77M259.09M192.43M386.14M263.35M468.46M287.41M106.04M76.79M25.32M77.46M
Total Debt-------37.72M33.13M33.26M37.57M4.29M680.00K857.00K
Net Debt-692.89K-3.61M-31.80M-75.77M-259.09M-192.43M-386.14M-225.63M-435.33M-254.14M-68.47M-72.50M-24.64M-76.60M

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--414.31K-8.29M-2.84M-11.87M-46.32M-84.11M-91.95M-120.70M-152.65M-175.58M-147.06M-96.75M-78.40M
Investing Cash Flow--1.88M-3.17M-8.64M-30.81M-34.15M-37.29M-36.60M-46.96M-23.83M-1.62M3.20M0-5.69M
Financing Cash Flow-5.21M39.66M55.44M226.00M13.80M315.08M5.76M373.58M-5.27M-5.11M114.74M44.81M136.82M
Capital Expenditure01.88M3.17M8.64M30.81M31.28M37.29M36.60M47.49M24.18M1.62M1.06M05.56M
Free Cash Flow--2.30M-11.47M-11.48M-42.68M-77.60M-121.40M-128.55M-168.20M-176.83M-177.21M-148.12M-96.75M-78.40M
FCF to OCF-554.14%138.29%403.71%359.63%167.54%144.33%139.81%139.35%115.84%100.92%100.72%100.00%100.00%

Earnings

Report DateApr 20, 2017Aug 23, 2017Nov 10, 2017Feb 15, 2018Apr 27, 2018Aug 24, 2018Nov 7, 2018Feb 14, 2019Apr 24, 2019Aug 23, 2019Nov 8, 2019Feb 14, 2020Apr 28, 2020Aug 20, 2020Nov 12, 2020Feb 17, 2021Apr 28, 2021Aug 19, 2021Nov 11, 2021Feb 17, 2022Apr 28, 2022Aug 24, 2022Nov 10, 2022Feb 23, 2023May 23, 2023Aug 30, 2023Nov 9, 2023Feb 21, 2024Apr 29, 2024Aug 5, 2024Nov 27, 2024Feb 25, 2025May 14, 2025Aug 28, 2025Nov 26, 2025Feb 24, 2026May 7, 2026Aug 6, 2026
EPS Estimate--------------8.61-7.87-11.04---5.48-6.02--6.74-4.90----------0.12-0.09-0.06-0.06-0.04-0.04
EPS Actual-0.43-0.58-0.64-0.82-0.93-1.36-0.83-1.22-1.25-1.42-1.22-1.66-1.41-167.00-168.00-204.00-1.04-2.18-160.00-208.00-1.95-149.00-101.00-2.97-2.28-4.00-0.91-1.08-0.03-0.28-0.730.02-24.00-14.00-10.00-0.03-0.03-0.03
Surprise--------------1839.61%-2034.69%-1747.83%---2819.71%-3355.15%--2110.68%-1961.22%----------19900.00%-15455.56%-16566.67%50.00%25.00%25.00%
TimingPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap51.12M
Enterprise Value58.24M
Trailing P/E0.00
Forward P/E0.00
Price / Sales42.22
Price / Book3.80
EPS-0.16
Book Value0.035
Revenue (TTM)1.21M
Gross Profit (TTM)690.00K
EBITDA-83.22M
Profit Margin0.00%
Operating Margin-6011.29%
Return on Equity-426.97%
Return on Assets-124.89%
Shares Outstanding672.67M
Shares Float610.39M
Beta2.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 3, 20261:100